GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » Cash And Cash Equivalents

EUDA Health Holdings (EUDA Health Holdings) Cash And Cash Equivalents : $0.32 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is EUDA Health Holdings Cash And Cash Equivalents?

EUDA Health Holdings's quarterly cash and cash equivalents increased from Dec. 2022 ($0.06 Mil) to Mar. 2023 ($0.84 Mil) but then stayed the same from Mar. 2023 ($0.84 Mil) to Jun. 2023 ($0.32 Mil).

EUDA Health Holdings's annual cash and cash equivalents declined from Dec. 2021 ($0.19 Mil) to Dec. 2022 ($0.06 Mil) but then increased from Dec. 2022 ($0.06 Mil) to Dec. 2023 ($0.19 Mil).

EUDA Health Holdings Cash And Cash Equivalents Historical Data

The historical data trend for EUDA Health Holdings's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EUDA Health Holdings Cash And Cash Equivalents Chart

EUDA Health Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Cash And Cash Equivalents
0.25 0.19 0.06 0.19

EUDA Health Holdings Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23
Cash And Cash Equivalents Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.06 0.84 0.32 0.19

EUDA Health Holdings Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

EUDA Health Holdings  (NAS:EUDA) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

EUDA Health Holdings Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of EUDA Health Holdings's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

EUDA Health Holdings (EUDA Health Holdings) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EUDA Health Holdings Ltd (NAS:EUDA) » Definitions » Cash And Cash Equivalents
Comparable Companies
STRM ZCMD AKLI PBSV ETAO CRVW HCTI BEAT UPH BFRG GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC
Traded in Other Exchanges
N/A
Address
1 Pemimpin Drive No. 12-07, One Pemimpin, Singapore, SGP, 576151
Website
https://www.euda.com
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
Executives
Kongyew Wong director C/O 6 EU TONG SEN STREET, #08-13, THE CENTRAL U0 059817
Chen Wei Wen Kelvin director, officer: CHIEF EXECUTIVE OFFICER C/O 1 PEMIMPIN DRIVE #12-07,, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Alfred Lim director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Kim Hing Chan director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
David Francis Capes director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Daniel Tan officer: CHIEF TECHNOLOGY OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Steven John Sobak officer: CHIEF FINANCIAL OFFICER C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPIN SINGAPORE, SINGAPORE U0 576151
Lim Thien Su Gerald director C/O 1 PEMIMPIN DRIVE #12-07, ONE PEMIMPI, SINGAPORE U0 576151
Tan Meng Dong (james) director, 10 percent owner, officer: Chief Executive Officer UNIT 2003 KINGKEY 100, TOWER B, 5015 SHENNAN EAST ROAD, LUOHU DISTRICT, SHENZHEN/GUANGDONG F4 518000
Alexander K. Arrow director PO BOX 3094, REDWOOD CITY CA 94064
Kwong Yeow Liew director RM 2313-2315, BLOCK B, ZHONGSHEN GARDEN, SHENZHEN F4 518101
Yap Guan Hong William director, officer: Chief Financial Officer 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
Ajay Rajpal director 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817
8i Holdings 2 Pte Ltd 10 percent owner C/O 6 EU TONG SEN STREET, #08-13 THE CENTRAL, SINGAPORE U0 059817